Stefanie Howell

Neuroscientist

University of Arkansas

Faculty Researcher

5 h-index 28 pubs 90 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Stefanie Howell leads a research group focused on understanding disease mechanisms and developing therapeutic interventions. Her recent work includes the development of a covalent chemical probe targeting the Chikungunya virus nsP2 cysteine protease, demonstrating antialphaviral activity and proteome-wide selectivity. This research aims to identify potential antiviral agents against alphaviruses.

Howell's research also investigates the impact of neurological conditions on physiological processes. She has published studies examining sex differences in sleep architecture following traumatic brain injury, with implications for memory and recovery. Additionally, her work includes analyzing sleep-wake disturbances in patients recovering from stroke, comparing outcomes between hemorrhagic and ischemic events, and exploring sleep architecture and apnea in supra- and infratentorial stroke patients.

Her scholarship metrics include an h-index of 5, with 28 total publications and 90 total citations. Howell has received federal funding from the NIH/National Heart Lung and Blood Institute for a project focused on the prevention of heart failure induced by Doxorubicin, where she serves as Principal Investigator. She collaborates with researchers at the University of Arkansas at Fayetteville and the University of Arkansas for Medical Sciences.

Metrics

h-index: 5
Publications: 28
Citations: 90

Selected Publications

Correlation between non-alcoholic Steatohepatitis and Hepatocellular carcinoma in patients in a Rural State (2025)

DOI OpenAlex
Subcapsular Splenic Hematoma After Diagnostic Colonoscopy: A Case Report (2024)

Cureus DOI OpenAlex
Infectious Thrombophlebitis of the Left Internal Jugular Vein With Tissierella praeacuta Isolation in a 71-Year-Old Female: A Case Report (2024)

Cureus 1 citation DOI OpenAlex